It’s like having a thousand pharmacists making house calls simultaneously, effortlessly, and in every language your patients speak.
That’s the power of Zoë Adherence.
This isn’t another robocall. Zoë isn’t reading from a script. She’s listening, responding, adapting. Powered by the BAS-8 framework and elevated through conversational AI, Zoë brings human nuance and behavioral science into every call. She’s smart. She’s multilingual. And most importantly, she connects.
The BAS-8 asks the right questions. The ones that uncover the “why” behind adherence.
These aren’t checkboxes. They’re moments of truth. And Zoë doesn’t just collect the answer, she explores the story behind it. She hears when someone says, “I felt dizzy so I stopped,” or, “I’m just tired of taking pills every day.” She catches tone, hesitation, even the silence that means something else is going on.
And because she speaks the patient’s language, whether Portuguese in São Paulo, Arabic in Cairo, or Mandarin in Vancouver, Zoë makes those BAS-8 questions land with empathy. They don’t sound clinical. They sound human.
Zoë calls when it matters most: not when it’s convenient for your system, but when it’s comfortable for the person on the other end. Morning, evening, after a shift, or once the kids are asleep. Zoë meets people where they are, and when they’re ready.
Whether you’re reaching 1,000 patients or 100,000, Zoë scales without limits. No burnout. No bottlenecks. Just consistent, high-fidelity conversations that transform BAS-8 answers into clean, structured data that is ready for pharmacists, care teams, and predictive modeling.
Because adherence isn’t about ticking boxes. It’s about understanding behavior. It’s about the story behind the “no.”
With Zoë, the BAS-8 isn’t just a survey anymore, it’s a conversation. It’s a map of risk and resilience, updated in real time, across every patient you serve.
And for the first time, that story is finally being told at scale, with empathy, and in every language your patients speak.
So, what story do your patients want to tell you? Let Zoë ask the questions and let you hear the answers.
Copyright © 2023 Adherence. All Rights Reserved.
Adherence Cartography™, Behavioral Adherence Stability Scale (BAS-8™), and Behavioral Fragility Score (BFS™) are trademarks of Adherence.
MMAS®, MMAS-4™, MMAS-8™, Morisky Medication Adherence Scale™, and Morisky Scale™ are registered trademarks or trademarks owned by Dr. Donald E. Morisky.
health tech, digital health, telehealth, healthcare innovation, medical technology, ehealth, health informatics, remote patient monitoring, mhealth, telemedicine, patient engagement, wearable health devices, health app, ai in healthcare, telehealth solutions, virtual care, health tech startups, connected health, population health management, healthcare analytics, personalized medicine
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
Support the Bhutan Adherence Initiative
Help bring the BAS-8, BFS™ and Ξxpert training to Bhutan’s health system in partnership with the Ministry of Health. Your contribution directly advances evidence-based care.
[Donate Now]